Breaking News on Outsourcing PharmaDaily
Thursday 03 January 2008
Forward to a colleague |
|
|
| Breaking News on Outsourcing Pharma |
||
|
||
| Daily
Thursday 03 January 2008 |
Forward to a colleague |
|
|
Access Full Stories  More pharmas implicated in Iraq bribery probeWhile GSK, AstraZeneca and Eli Lilly have hit the headlines in the UK Serious Fraud Office's (SFO) investigation into illegal bribes paid to Saddam Hussein's Iraqi regime, many more pharma firms are on the organisation's... Read New China:US preclinical partnership formed US-based MPI Research and China's Shanghai Medicilon have formed a joint venture in preclinical services, as they position themselves to cash in on what is a budding market sector in China... Read Galapagos scores first oncology contract Galapagos' services arm has scored another lucrative contract from big pharma - its first in the field of oncology - as it continues to broaden its experience... Read Quintiles in $3bn investment deal One Equity Partners (OEP), the private equity arm of JPMorgan Chase, is in the process of selling its stake in Quintiles for a reported sum of over $3bn... Read Merck divests API plant; hands out large contract Merck & Co has handed the reins of one of its US active pharmaceutical ingredient (API) manufacturing facilities over to new a owner, who has also secured a lucrative contract manufacturing deal with the drug... Read |
|
|||||||||||
All News Headlines for: January | December | November |
|||||||||||||
|
Related Industry News New drug target leaves lung cancer cells alone, lonely and dying It seems even tumour cells can get lonely; scientists have discovered that by cutting off a key gene, lung cancer tumour cells are left 'homeless' and they can't survive on their own... Read A drug cocktail to bust brain tumours A team of US researchers have uncovered a cocktail of three drugs that could be effective at treating every patient with a particular type of brain cancer that typically has a dismal prognosis... Read Mapping the 'human embryome' in BioTime BioTimes' subsidiary, Embryome Sciences, is planning to build a relational database that will help identify the hundreds of cell types that can be made from human and mouse embryonic stem cells... Read Pfizer buys CovX to bulk biologics pipeline Pfizer, the world's largest pharma firm, has reached into its pockets to buy CovX, a privately-held US biotech that specialises in combining the strengths of peptides and antibodies into new drugs... Read
|
|||||||||||||
|
|
|
|||
| Forward to a colleague |
|||||
|
To continue to receive this newsletter in your inbox, please add newsletter@OutSourcing-Pharma.com to your address book |
|
Update preferences | Change your email address | Unsubscribe |
||
Contact us: Advertising | Recruitment | Privacy policy | Terms & conditions | Feedback |
||
| © 2008 - Decision News Media S.A.S - All Rights Reserved Le Belem - 355, rue Vendemiaire - 34000 Montpellier - France http://www.decisionnewsmedia.com |
||
